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Mitochondria are double-membrane-bound organelles that are responsible for the
generation of most of the cell’s energy. Mitochondrial dysfunction has been implicated
in cellular senescence in general and ovarian aging in particular. Recent studies exploited this association by studying mitochondrial DNA (mtDNA) copy number as a
potential biomarker of embryo viability and the use of mitochondrial nutrients and
autologous mitochondrial transfer as a potential treatment for poor ovarian function
and response.
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1 | INTRODUCTION

increased over the past decade in the United States, where DOR ac-

Twentieth century witnessed significant changes in the socioeconomic

2004 and 17% in 2014, and the number of fresh IVF cycles using non-

counted for 8% of assisted reproductive technology (ART) cycles in
parameters that define the role of women in the society. In 1900,

donor oocytes performed for women with DOR increased from 6947

<20% of women participated in the labor force in the United States.

in 2004 to 17 115 in 2014. Similarly, the number of total oocyte dona-

This number increased to 33% by 1950 and 60% by 2000.

tion cycles (fresh and frozen-thawed oocyte or embryo) in the United

In parallel with women’s increasing participation in the workforce

States increased from 12 454 in 2004 to 19 375 in 2014.5

and realization that college education increases employment and

There are several potential molecular mechanisms contributing

earning potential, college graduation rate that was less than 4% for

to ovarian aging, including impaired DNA repair,6 telomere shorten-

women in the United States in 1940 reached 32.5% in 2015, equaling

ing,7 metabolic/energetic disorders, and mitochondrial dysfunction.

that of men. These changes made a significant impact on women’s de-

Understanding the mechanisms of reproductive senescence and

cision regarding the timing of childbearing, and the number of women

developing strategies to prevent or delay ovarian aging would have

delivering their first child after the age of 35 increased from 1/100 in

significant medical and social implications. In this review, we will sum-

1

1970 to 1/12 in 2006.

marize data related to the association of mitochondrial dysfunction

However, delaying childbearing was not consequences as re-

with ovarian aging.

flected by the data provided by the Society of Assisted Reproductive
Technology (SART) regarding women undergoing infertility treatment
in the United States. Indeed, despite a steady increase in human longevity over the past centuries, culminating in a life expectancy at birth

2 | MITOCHONDRIA:
STRUCTURE AND FUNCTION

that is longer than 80 years for women in the United States, age of
menopause remained essentially unchanged at approximately 50, and
2,3

scientific research failed to impact upon ovarian aging.

Mitochondria are double-membrane-bound organelles that are ubiquitously present in the cytoplasm of eukaryotic cells and generate

Within the context of assisted reproduction, ovarian aging com-

most of the energy of the cell in the form of adenosine triphosphate

monly refers to the declining potential of ovaries to produce oocytes

(ATP). In addition to supplying cellular energy, mitochondria are in-

in adequate number or quality in response to controlled ovarian stim-

volved in other cellular activities, such as calcium homeostasis and

4

ulation. Patients who present with ovarian aging are commonly di-

substrate oxidation, and play a key role in the regulation of cell cycle,

agnosed with diminished ovarian reserve (DOR) and offered in vitro

differentiation, senescence, and death.8

fertilization (IVF) using either their own eggs or donated eggs or em-

Mitochondrial oxidative phosphorylation (OXPHOS) system is the

bryos. The number of women undergoing IVF for DOR has steadily

metabolic pathway in which cells use enzymes to oxidize nutrients,
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FIGURE 1

thereby releasing energy, which is used to produce ATP. OXPHOS

Electron transport chain

oxidative damage.12 Free radicals (such as superoxide anion [O2−] or

depends on the activity of five multi-enzymatic complexes (CI-CV)

hydrogen peroxide [H2O2]) are compounds that have one or more

embedded in the inner mitochondrial membrane and of two mo-

unpaired (excess) electrons. Free radicals can readily react with sur-

bile electron carriers, coenzyme Q10 (CoQ10) and cytochrome c

rounding molecules and cause damage to DNA, proteins, and lipids by

(Cytc), collectively referred to as the electron transport chain (ETC.)

stealing their electrons through a process called oxidation. Another

(Figure 1). The OXPHOS system couples the electron flow with proton

term that is often used within this context is reactive oxygen species

translocation across the inner mitochondrial membrane generating an

(ROS), which denotes chemically reactive species containing oxygen,

electrochemical gradient between the mitochondrial matrix and the

and includes the free radical superoxide (O2−) and also hydroxyl radi-

intermembrane space, which then fuels ATP synthesis (Figure 1).

cal, singlet oxygen, and peroxides. Mitochondrion is the main source

Mitochondria generate much of the endogenous reactive oxygen

of free radicals and reactive oxygen species (ROS) in the cell.

species (ROS), a potentially toxic by-product of OXPHOS. These or-

The mitochondrial free radical theory of aging proposes that the

ganelles also integrate the mitochondrial permeability transition pores

high levels of free radicals and ROS within mitochondria may result in

(mtPTPs) that initiate cell death when the mitochondrial energy func-

mtDNA mutations leading to loss of synchrony in the production on

tion declines. Therefore, inefficiency in the OXPHOS system may re-

functional ETC. proteins by mtDNA and nuclear DNA, which results

sult in the generation of high levels of ROS, which may then lead to

in partial uncoupling of the respiratory chain.13,14 Indeed, due to the

cellular dysfunction and apoptosis. In fact, mitochondrial dysfunction

close proximity of mtDNA to ETC., its lack of protective histones, and

is associated with heterogeneous group of pathologies and metabolic

limited repair mechanisms, the mutation rate of mtDNA is almost 25

syndromes such as atherosclerosis, type 2 diabetes, and neurodegen-

times higher than that of nuclear DNA.15 The proposed model fur-

erative disorders.9

ther suggests that increased mtDNA mutations would cause further

Mitochondria are unique organelles as they contain DNA.

accumulation of ROS and increased mtDNA mutations. This cycle

Mitochondrial DNA (mtDNA) in mammals is a double-stranded circular

could result in an exponential increase in mtDNA mutation burden,

molecule of about 16.6 kb and contains 37 genes. An estimated 2-10

which could range from ATP reduction up to cell cycle arrest or even

mtDNA copies are found in each mitochondrion and 100-10 000 in

apoptosis. Indeed, increased ROS levels, accumulated mtDNA muta-

each somatic cell. Mitochondrial DNA encodes two ribosomal RNAs,

tions, and a decline in mitochondrial function have been reported in

22 transport RNAs, and 13 proteins, all of which are part of the ETC.10

aging. Also consistent with this theory, mouse models that are prone

The 13 proteins encoded by mtDNA account for only a small portion

to mtDNA mutations due to a PolgA (the nucleus-encoded catalytic

of approximately 80 proteins required for the formation of ETC. and

subunit of mtDNA polymerase) deficient in proof-reading function,

1500 proteins that function within mitochondria. Therefore, appropri-

are associated with accumulated mtDNA mutations and a premature

ate function of the ETC. and the mitochondria requires coordinated

aging phenotype, leading to both male and female infertility.16 Recent

transcription and translation from both nuclear and mitochondrial

studies showed that maternally inherited mtDNA mutations alone or

DNA.11

in combination with somatic mtDNA mutation may induce the aging
phenotype and reduce the life span in mice, and that the reduced fer-

3 | PROPOSED MECHANISMS ON HOW
MITOCHONDRIAL DYSFUNCTION MAY
CONTRIBUTE TO OVARIAN AGING

tility caused by mtDNA mutations in the maternal germline could be
reversed by the introduction of normal mtDNA.17,18 These findings
demonstrate that experimental introduction of mtDNA mutations in
animal models results in aging in general and ovarian aging in particular. However, recent studies show that mtDNA mutation burden

In 1956, Dr. Denham Harman proposed the mitochondrial free radi-

associated with human aging is very low,19 and biopsies of embryos

cal theory of aging (MFRTA), which suggests that mitochondrial free

for women over 40 years old do not show an increase in mtDNA mu-

radicals, produced as by-products during normal metabolism, cause

tations.20 These observations strongly suggest that a model based on

|
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MFRTA is an oversimplification and fails to explain the mechanism of

gene during development.32,48 Moreover, Udagawa et al.49 established

ovarian senescence and overall human aging.

oocyte-specific Drp1-deficient mice and found that mitochondrial

Multiple mitochondrial dysfunctional signaling pathways, besides
mitochondrial ROS, are implicated in establishing cellular senescence

fission is essential for follicular maturation and ovulation in an age-
dependent manner.

(defined as an irreversible state of G1 cell cycle arrest in which cells are

Removal of unfolded or misfolded mitochondrial proteins to main-

refractory to growth factor stimulation). These include impaired mi-

tain protein hemostasis (proteostasis) is a critical function for mitochon-

tochondrial fusion and fission (mitochondrial dynamics),21,22 defective

dria which houses several proteases that are in different mitochondrial

mitochondrial electron transport chain (ETC.),23,24 bioenergetic imbal-

compartments including CLPP, AFG3L2, PARAPLEGIN, OMA1, PHBs,

ance,23,25,26 altered mitochondrial metabolism,27,28 and altered mito-

OMI, and PARL. Defects in the mitochondrial protein surveillance and

29

chondrial membrane potential. Above-mentioned pathways highlight

quality control system are associated with numerous disorders asso-

the perspective for understanding the effects of mitochondrial stress

ciated with impaired mitochondrial function.33,50-59 In addition, genes

on aging, linking mitochondrial dysfunction, and aging through the

responsible for maintenance of mitochondrial dNTP pool and related to

process of cellular senescence. However, the mechanism(s) by which

mitochondria OXPHOS also play important roles in mitochondrial func-

these factors promote cellular senescence, and whether these path-

tion and their absence results in severe phenotypes.9,30,60-74 Knockout

ways are conserved in all senescent cells, for example, ovarian somatic

mouse models of genes involved in mtDNA stability, transcription,

and germ cells, is poorly understood. Investigating the mechanisms of

translation, mitochondrial dynamics, mitochondrial protein quality con-

mitochondrial dysfunction in the ovary may help us understand the

trol, and associated phenotypes are summarized in Table 1.

biology of ovarian senescence, providing new potential targets to treat
age-related diseases.

5 | CLINICAL IMPLICATIONS FOR
TESTING AND TREATMENT

4 | GENES IMPORTANT FOR
MITOCHONDRIAL FUNCTION

5.1 | mtDNA copy number as a predictor of embryo
viability

Mitochondrial diseases are mostly caused by mutations in nuclear

There seems to be a close relationship between mitochondrial dys-

DNA and in some cases (about 15%) in mtDNA, which affect mito-

function and the decline of oocyte quality and embryo developmental

chondrial function.30 Several reports based on the use of transgenic

potential in human and in mammalian aging models.75

methods have revealed a key role for specific genes in mitochondrial

The number of mitochondria in mammalian cells ranges from a few

diseases.31-36 Regulation of mtDNA gene expression is extremely im-

hundred to thousands, with the highest number observed in mature

portant for modulating the OXPHOS capacity in response to meta-

oocytes at approximately 100 000.76 As the mitochondria are inher-

bolic requirements and in stress conditions.

37

ited exclusively from the oocyte, and the replication of mtDNA only

To ensure proper mitochondrial function, mtDNA genome must be

resumes at blastocyst stage after the differentiation of the inner cell

replicated, transcribed, and translated accurately. All the components

mass and the trophectoderm,77,78 the mtDNA copy number remains

involved in mtDNA replication and transcription are encoded in the

unchanged during cleavage stages and reflects the mtDNA content of

nuclear genome, and mutations of genes essential for mtDNA repli-

the oocyte.76,79-82

cation (POLγ and TWINKLE) and for transcription/translation (TFAM,

Recent studies suggest that elevated mtDNA copy number is asso-

TFB1M, mTERFs, POLRMT, LRPPRC, and DARS2) are all embryonic

ciated with decreased implantation potential in human IVF embryos.

lethal except mTERF1.34-36,38-44

Fragouli et al.75 assessed day 3 and day 5 embryos by using a combi-

Mitochondria are dynamic organelles that are constantly under-

nation of array-comparative genomic hybridization (aCGH), real-time

going fusion and fission to adapt to cellular energetic demands and

quantitative PCR (RT-qPCR), and next-generation sequencing (NGS)

maintain the mitochondrial function. A number of proteins belonging

and found that a significantly higher mtDNA copy number was ob-

to the dynamin GTPase protein family are involved in mitochondrial

served in embryos from older women. Additionally, mtDNA levels

fission and fusion.45 To explore the implication of dynamic genes in

were elevated in aneuploid embryos (independent of age) compared

mitochondrial function, several laboratories have investigated the im-

to euploid ones and euploid blastocysts that failed to implant com-

pact of global genetic disruption of genes in mouse. The work from

pared to those that implanted. Authors established a mtDNA quan-

31

revealed that knockout of Mfn1 or Mfn2, which are re-

tity threshold, above which pregnancy did not occur. In a subsequent

sponsible for mitochondrial fusion in mouse, results in embryonic

Chen et al.

study, Diez-Juan et al.83 found that a higher mtDNA copy number in

lethality due to a severe developmental delay and placental defects.

euploid embryos is indicative of lower embryo viability and implan-

OPA1, another gene involved in mitochondrial fusion, is targeted to

tation for both blastocysts and cleavage-stage embryos. The above-

the inner mitochondrial membrane. Homozygous deletion of OPA1

mentioned studies proposed that mtDNA copy number is an exciting

is also embryonic lethal with a block in development.46,47 DRP1, a

new paradigm for embryo quality assessment. The importance of mi-

large GTPase, mediates mitochondrial fission. The complete loss of

tochondrial threshold in oocyte competence is also shown on many

Drp1 in mice is embryonic lethal, revealing the essential role of this

animal models including mouse,84 pig,85 and cattle.86,87

Gene function

Metalloprotease, a member of the AAA protein
family.

m-AAA protease, assembly of CI, CIII, and CIV,
mitochondrial protein synthesis, mitochondrial
morphology, and network maintenance

Metalloprotease, degrade OPA1 to prevent
mitochondrial fusion

Mitochondrial chaperone, mtDNA maintenance,
mitochondrial dynamics

Mitochondrial chaperone, mtDNA maintenance,
mitochondrial dynamics

Serine protease, clearance of unfolded proteins

Mitochondrial inner membrane protease,
proteolytic cleavage OPA1 to inhibit apoptosis

Mitochondrial serine/threonine protein kinase,
involved in mitochondrial fission and motility

SPG7

AFG3L2

OMA1

PHB1

PHB2

HTRA2/
OMI

PARL

PINK1

Mitochondrial fusion

Mitochondrial fusion and cristae structure

Mitochondrial fission, mitophagy, apoptosis
regulation

Mitochondrial fusion

MFN2

OPA1

DRP1

DRP1

mtDNA replication (catalytic subunit of Polγ)

mtDNA replication (accessory subunit of Polγ)

POLGA

POLG2

mtDNA stability, replication, transcription, and translation

Mitochondrial fusion

MFN1

Mitochondrial dynamics

Mitochondrial matrix ATP-dependent protease

CLPP

Both males and females were fertile

Both males and females were infertile (reduced macroscopic size of testes and ovaries already at age 3 months)

Global knockout reproductive phenotype

(Continues)

36

34

49

32, 48

46,47

31

31

52

11

8, 10

55

54

53

45

50, 51

33

Global
knockout
reference

|

Embryonic lethal (E8.0-8.5)

Embryonic lethal (E7.5-8.5)

Drp1 oocyte specific knockout mice: female infertility,
defective for follicular maturation and ovulation, reduced
ovulation activity.

Embryonic lethal

Embryonic lethal (E13.5)

Embryonic lethal (E10.5-E11.5)

Embryonic lethal (E10.5-E11.5)

Parkinson’s disease, evoked release of striatal dopamine,
and catecholamine are reduced

Severe growth retardation, cachexia, atrophy of thymus,
and spleen. Premature death by 8-12 wks of age. Neuronal
death in thalamus and striatum.

Parkinson like phenotype: neurodegeneration with loss of
neurons in the striatum. Premature death by P30.

Embryonic lethal

Embryonic lethal

Viable, marked obesity with metabolic alterations, reduced
energy expenditure, and altered thermogenic response

Severe progressive paralysis with premature death by P15,
impaired axonal development, and delayed myelination

Axonal degeneration, cerebellar, and hippocampal
degeneration accompanied by gliosis

Impaired survival and hearing, resistance to ulcerative
dermatitis, growth retardation, motor activity reduction

Global/conditional knockout phenotype

Knockout mouse models of genes involved in mitochondrial function

Mitochondrial protein quality control

Gene

TABLE 1
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mtDNA replication (helicase)

mtDNA maintenance and mtDNA transcription

Mitochondrial transcription and translation

Transcription initiation at the light-strand
promoter of the mtDNA

Transcription terminator of the mtDNA

Mitochondrial ribosomal biogenesis

Translation/stability of the mitochondrial mRNAs

Mitochondrial aspartyl-tRNA synthetase

TWINKLE

TFAM

TFB1M

MTERF1

MTERF3

MTERF4

LRPPRC

DARS2

Adenine nucleotide translocase

Adenine nucleotide translocase

Adenine nucleotide translocase

Synthesis of deoxypyrimidine nucleoside
triphosphates

Metabolism of nucleotides

Synthesis of dNTPs

Unknown function

Involved in initiating a caspase-independent
pathway of apoptosis

Biosynthesis of the iron-sulfur clusters

Mitochondrial sulfur dioxygenase (SDO)

ANT1

ANT2

ANT4

TK2

TP/UP

RRM2B

MPV17

AIF

FXN

ETHE1

Maintenance of mitochondrial dNTP pool

Gene function

(Continued)

Gene

TABLE 1

Ethylmalonic encephalopathy, growth arrest at postnatal
day 15, lethal at 5-6 wks after birth. Reduced motor
activity

Embryonic lethal (E6.5)

Neuronal degeneration, reduction in CI activity

Renal degeneration, hearing loss, mild hepatopathy, and
myopathy

Severe renal failure, growth retardation, and early mortality

Leukoencephalopathy

Growth retardation, hypothermia and early mortality,
neurodegeneration

Viable and exhibited apparently normal development

Postnatal growth retardation with lactic acidosis, hematopoietic failure

Mitochondrial myopathy, progressive cardiac hypertrophy,
metabolic abnormalities, severe exercise intolerance

Embryonic lethal (E8.5)

Embryonic lethal (before E12.5)

Embryonic lethal (before E8.5)

Embryonic lethal (E8.5-E10.5)

Viable, with normal oxidative phosphorylation capacity

Embryonic lethal (E8.5)

Embryonic lethal (E8.5-10.5)

Embryonic lethal

Global/conditional knockout phenotype

Male mice were infertile Female mice are fertile but
produce a smaller number of progeny

Global knockout reproductive phenotype

30

9

73,74

71,72

70

67-69

64-66

62,63

61

60

44

35

43

42

41

40

39

38

Global
knockout
reference
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It is noteworthy that accurate quantification of the mtDNA copy

initial findings are very encouraging and suggest a potential benefit from

number requires robust techniques. In experimental settings, qPCR is

the use of mitochondrial nutrients, well-designed clinical studies are re-

commonly used to quantitate the mtDNA copy number, with a chal-

quired to test the clinical efficacy and safety.

lenging normalization to nuclear DNA when single cells (or 5-10 cells
as in the case of blastocyst biposies) are used. Another platform called
droplet digital PCR is shown to be a superior method to qPCR for as-

5.3 | Mitochondrial transfer

sessment of gene copy number variation,87-89 the accuracy of which

Two decades ago, transfer of cytoplasm from an oocyte obtained

is essential for studies requiring mtDNA copy number correlation to

from a younger woman into the oocyte of an older woman was re-

phenotypic outcomes of oocytes and embryos. More recently, a probe-

ported to improve oocyte competence and embryo development.112

based, single-tube multiplex method providing high specificity while

Subsequently, more than 50 successful live births have been achieved

eliminating well-to-well variability has also been described.90 It is likely

with this method.113 However, due to lack of adequate experimen-

that some of these more advanced approaches and/or NGS will be uti-

tal data and the potential risk associated with the transmission third-

lized in clinical settings in the future, where the impact of mtDNA copy

party genetic material, the US Food and Drug Administration (FDA)

number analysis on clinical outcomes will need to be established.

suggested (in 2002) that donor cytoplasmic transfer should be suspended pending the outcome of further studies.
As oocyte cytoplasm has numerous components with yet unknown

5.2 | Mitochondrial nutrients

functions, mitochondrial replacement has been proposed as an alterna-

As mitochondrial dysfunction is associated with ovarian aging and is

tive. Indeed, transfer of isolated mitochondria is sufficient to improve

believed to negatively affect reproduction, an improvement in mito-

mitochondrial function and reproduction in the mouse.114 Spindle

chondrial performance could potentially slow or reverse the decline in

chromosome transfer or pronuclear transfer (PNT) of oocytes has also

reproductive function associated with aging. Mitochondrial nutrients

been proposed as potential treatments for human diseases caused by

are naturally occurring agents that have been used to boost energy-

mtDNA mutations.115,116 However, these approaches received a signifi-

91

producing capacity of mitochondria.

These include α-lipoic acid

cant amount of criticism worldwide due to the risk of heteroplasmy and

(ALA), coenzyme Q10 (CoQ10), resveratrol, sirtuin 3 (Sirt3), rapamy-

potential long-term health consequences in the offspring.117,118 Indeed,

cin, and L-carnitine among others.17 ALA is a coenzyme that plays an

studies in mice showed that heteroplasmy is associated with cognitive

important role in mitochondrial metabolism. The reduced form of ALA

abnormalities119 and a phenotype resembling early-onset metabolic

(dihydrolipoic acid) is a powerful mitochondrial antioxidant formed by

syndrome.120 Nevertheless, mitochondrial transfer from a donor has re-

92

NADH-dependent mitochondrial dihydrolipoamide dehydrogenase,

cently been approved for use in humans in the UK for the treatment of

and ALA is required for normal embryonic development in mice.93

carriers of severe mitochondrial disorders (February 3, 2015).

CoQ10 is a lipid-soluble electron transporter, which transports electrons

In the setting of age-related infertility, autologous transfer of

from complexes I and II to complex III in ETC. (Figure 1) and is critical for

mitochondria from somatic cells has been proposed to avoid risks

the stabilization of complex III.94 CoQ10 is also involved in the transport

associated with heteroplasmy. This method utilizes mitochondria ob-

of protons into the mitochondria to maintain the membrane potential

tained from the ovarian germline cells to eliminate the tissue-specific

95

and ATP production.

Several studies reported decreased levels of
96,97

CoQ10 associated with tissue-specific senescence.

differences that could potentially affect embryonic development.121,122

In addition, sup-

Autologous germline mitochondrial energy transfer (AUGMENT) has

plementation of CoQ10 seems to restore mitochondrial function in the

recently been commercialized. Using this technology, a prospective

oocyte and delay ovarian aging in mice.98-100 Dietary supplementation

cohort study with historical controls by Fakih et al. reported an ap-

of CoQ10 could also possibly decrease aneuploidy rate in human oo-

proximately eightfold to 10-fold increase in clinical pregnancy rates

cytes.101 Resveratrol is a chemical reported to have the ability to delay

in a selected group of women with very poor IVF outcomes in the

aging and prevent age-related diseases by increasing the number of

past.123 A subsequent study using the same technology also reported a

102,103

Resveratrol

significant improvement in fertilization rates.124 While the initial stud-

was found to improve mitochondrial performance and the number and

ies showed significant improvement compared to the outcomes of the

quality of oocytes, protecting against the infertility associated with

same women in the past, they failed to achieve pregnancy in older

mitochondria and improving mitochondrial function.

ovarian aging in mice.104 Sirtuin 3 (SIRT3) is a molecule strongly impli-

women, and the true efficacy of this approach remains to be estab-

cated in aging, which can be activated by resveratrol and enhance mi-

lished in well-designed clinical studies without selection bias.

tochondrial biogenesis.105,106 It has recently been shown that inefficient
SIRT3 expression may impair the developmental competence of human
IVM oocytes via decreased mitochondrial biogenesis.107 Rapamycin was

6 | SUMMARY AND CONCLUSIONS

recently found to improve oocyte competence by increasing mitochondrial autophagy and renewal and to result in prolongation of reproduc-

Mitochondria play a number of key roles in cellular physiology and

tive life.108-110 L-carnitine, a small molecule which has a critical role in

have been strongly implicated in aging through a number of mecha-

fatty acid β-oxidation, could improve meiotic spindle assembly and mi-

tochondrial distribution in metaphase II (MII) oocytes.111 While these

nisms. Within the context of reproduction, mtDNA copy number may
constitute a test for the prediction of embryo viability, increasing the

WANG et al.

predictive efficacy of preimplantation genetic screening (PGS). In addition, nutrients improving mitochondrial function and replacement of
functional mitochondria into the germ cells may be used in the clinical
setting as a potential treatment for ovarian aging. All these exciting
clinical applications will need to be validated for safety and efficacy.
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